GlassScriptPhysician profile
Michael Nicolai
NPI 1144264029
$2,679.32
in general payments reported to CMS, 2019-2025
30 companies · $887 in 2025
The $887 reported for 2025 was more than what 83% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26.78 · 2020: $37.71 · 2021: $45.60 · 2022: $122 · 2023: $742 · 2024: $818 · 2025: $887.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,447.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,447.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $507.39 | 2019-2025 | |
| Abbvie INC. | $447.62 | 2023-2025 | |
| Novo Nordisk INC | $268.38 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $186.06 | 2022-2025 | Breztri, Farxiga, Airsupra |
| Lilly USA, LLC | $165.55 | 2023-2025 | Jardiance, Mounjaro, Zepbound |
| Glaxosmithkline, LLC. | $159.44 | 2023-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $150.75 | 2023-2025 | Jardiance, Synjardy |
| Novartis Pharmaceuticals Corporation | $84.53 | 2021-2022 | |
| Ibsa Pharma INC. | $76.07 | 2023-2025 | Tirosint, Licart, Tirosint |
| Vanda Pharmaceuticals INC. | $72.20 | 2025 | Fanapt |
| Abbott Laboratories | $57.06 | 2023-2024 | Freestyle Libre 2, Freestyle Libre 3 |
| Merck Sharp & Dohme LLC | $50.89 | 2025 | Capvaxive, Gardasil 9 |
| Cumberland Pharmaceuticals, INC. | $48.85 | 2023-2025 | Kristalose |
| Alk-Abello, INC | $40.17 | 2025 | Neffy, Grastek, Odactra |
| Becton, Dickinson and Company | $40.00 | 2024 | Bd Max System, Bd Max Instrument |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $32.55 | 2024-2025 | Voquezna |
| Exact Sciences Corporation | $28.84 | 2025 | Cologuard Collection Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $28.53 | 2022-2023 | Gattex |
| W. L. Gore & Associates, INC. | $28.42 | 2024 | Gore Seamguard Bioabsorbable Staple Line Reinforce |
| Teva Pharmaceuticals USA, INC. | $25.55 | 2022 | |
| Allergan, INC. | $24.48 | 2019-2020 | |
| Axsome Therapeutics, INC. | $22.56 | 2025 | Auvelity |
| Kyowa Kirin, INC. | $18.80 | 2024 | Crysvita |
| Renalytix Ai, INC. | $18.76 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Lundbeck LLC | $18.09 | 2025 | Rexulti |
| Seqirus USA INC | $17.00 | 2023 | Flucelvax Quadrivalent, Fluad Quadrivalent |
| Kowa Pharmaceuticals America, INC. | $17.00 | 2025 | Zoryve |
| Idorsia Pharmaceuticals US INC | $15.10 | 2024 | Quviviq |
| E.R. Squibb & Sons, L.L.C. | $14.43 | 2022 | |
| Amgen INC. | $14.25 | 2025 | Evenity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Nicolai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.